IL159993A0 - Platinum complexes and their use in cancer treatment - Google Patents
Platinum complexes and their use in cancer treatmentInfo
- Publication number
- IL159993A0 IL159993A0 IL15999302A IL15999302A IL159993A0 IL 159993 A0 IL159993 A0 IL 159993A0 IL 15999302 A IL15999302 A IL 15999302A IL 15999302 A IL15999302 A IL 15999302A IL 159993 A0 IL159993 A0 IL 159993A0
- Authority
- IL
- Israel
- Prior art keywords
- platinum complexes
- cancer treatment
- present
- concerns novel
- novel platinum
- Prior art date
Links
- 150000003057 platinum Chemical class 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001412 amines Chemical class 0.000 abstract 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31411501P | 2001-08-23 | 2001-08-23 | |
| PCT/IL2002/000687 WO2003017998A1 (en) | 2001-08-23 | 2002-08-21 | Platinum complexes and their use in cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159993A0 true IL159993A0 (en) | 2004-06-20 |
Family
ID=23218625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15999302A IL159993A0 (en) | 2001-08-23 | 2002-08-21 | Platinum complexes and their use in cancer treatment |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7122668B2 (ja) |
| EP (1) | EP1420775B1 (ja) |
| JP (1) | JP2005501859A (ja) |
| AT (1) | ATE457992T1 (ja) |
| CA (1) | CA2456348A1 (ja) |
| DE (1) | DE60235375D1 (ja) |
| ES (1) | ES2339228T3 (ja) |
| IL (1) | IL159993A0 (ja) |
| WO (1) | WO2003017998A1 (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9502799D0 (en) * | 1995-02-14 | 1995-04-05 | Johnson Matthey Plc | Improvements in platinum complexes |
| CA2523413A1 (en) | 2003-04-25 | 2004-11-11 | The Penn State Research Foundation | Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| CA2547275A1 (en) * | 2003-11-25 | 2005-06-09 | Platco Technologies (Proprietary) Limited | Platinum(ii) complexes, preparation and use |
| ES2327346T3 (es) * | 2004-09-01 | 2009-10-28 | Platco Technologies (Proprietary) Limited | Preparacion de complejos de platino (ii). |
| ES2257178B1 (es) * | 2004-09-30 | 2007-08-16 | Universidad Autonoma De Madrid | Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral. |
| ZA200806748B (en) * | 2006-01-30 | 2010-01-27 | Platco Technologies Proprietar | Preparation of platinum (II) complexes |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| WO2010027428A1 (en) | 2008-08-26 | 2010-03-11 | Massachusetts Institute Of Technology | Platinum ( iv) complexes for use in dual mode pharmaceutical therapy |
| WO2012177931A1 (en) | 2011-06-21 | 2012-12-27 | Massachusetts Institute Of Technology | Compositions and methods for the treatment of cancer |
| CA2844993A1 (en) | 2011-08-26 | 2013-03-07 | The Regents Of The University Of California | Platinum anticancer agents |
| WO2014160216A2 (en) | 2013-03-13 | 2014-10-02 | Massachusetts Institute Of Technology | Dual targeting anticancer agents |
| WO2014165782A2 (en) * | 2013-04-05 | 2014-10-09 | Massachusetts Institute Of Technology | Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety |
| CN103360431B (zh) * | 2013-07-16 | 2015-07-01 | 山西大学 | 一种以8-氨基喹哪啶为母体的金属配合物及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7304882A (ja) * | 1972-04-10 | 1973-10-12 | ||
| US4902797A (en) * | 1986-12-18 | 1990-02-20 | Shionogi & Co., Ltd. | Ammine-alicyclic amine-platinum complexes and antitumor agents |
| JPS63264492A (ja) * | 1986-12-18 | 1988-11-01 | Shionogi & Co Ltd | アンミン−脂環系アミン白金錯体および抗腫瘍剤 |
| US5026694A (en) * | 1987-04-13 | 1991-06-25 | The British Columbia Cancer Foundation | Platinum complexes with one radiosensitizing ligand |
| US4921963A (en) * | 1987-04-13 | 1990-05-01 | British Columbia Cancer Foundation | Platinum complexes with one radiosensitizing ligand |
| GB9502799D0 (en) | 1995-02-14 | 1995-04-05 | Johnson Matthey Plc | Improvements in platinum complexes |
| EP1536864A2 (en) * | 2002-09-11 | 2005-06-08 | Board Of Regents The University Of Texas System | Platinum complexes as antitumor agents in combination with biochemical modulation |
-
2002
- 2002-08-21 WO PCT/IL2002/000687 patent/WO2003017998A1/en active IP Right Grant
- 2002-08-21 DE DE60235375T patent/DE60235375D1/de not_active Expired - Lifetime
- 2002-08-21 AT AT02760540T patent/ATE457992T1/de not_active IP Right Cessation
- 2002-08-21 EP EP02760540A patent/EP1420775B1/en not_active Expired - Lifetime
- 2002-08-21 IL IL15999302A patent/IL159993A0/xx active IP Right Grant
- 2002-08-21 JP JP2003522518A patent/JP2005501859A/ja not_active Ceased
- 2002-08-21 ES ES02760540T patent/ES2339228T3/es not_active Expired - Lifetime
- 2002-08-21 US US10/487,154 patent/US7122668B2/en not_active Expired - Fee Related
- 2002-08-21 CA CA002456348A patent/CA2456348A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050090478A1 (en) | 2005-04-28 |
| EP1420775B1 (en) | 2010-02-17 |
| JP2005501859A (ja) | 2005-01-20 |
| ES2339228T3 (es) | 2010-05-18 |
| WO2003017998A1 (en) | 2003-03-06 |
| WO2003017998B1 (en) | 2003-08-28 |
| EP1420775A1 (en) | 2004-05-26 |
| US7122668B2 (en) | 2006-10-17 |
| DE60235375D1 (de) | 2010-04-01 |
| ATE457992T1 (de) | 2010-03-15 |
| CA2456348A1 (en) | 2003-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL159993A0 (en) | Platinum complexes and their use in cancer treatment | |
| EP1862457A3 (en) | Fluoropyrrolidines as dipeptidyl peptidase inhibitors | |
| MY126527A (en) | Novel dihydropyrimidines | |
| UA88645C2 (ru) | Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей | |
| BG105784A (en) | Triazole compounds with dopamine-d3-receptor affinity | |
| GEP20053488B (en) | Novel Spiro Compounds | |
| MY136520A (en) | Novel compounds | |
| HK1096392A1 (en) | Substituted heterocycles | |
| MXPA04003796A (es) | Tioacetamidas sustituidas. | |
| ZA200500908B (en) | Ruthenium anticancer complexes | |
| IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
| IL156774A0 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| PL374080A1 (en) | Processes for the preparation of fibrinogen | |
| YU68702A (sh) | Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka | |
| DE60121804D1 (de) | Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin | |
| MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| EP1601756A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFECTIOUS DISEASES USING ALPHA (2) MACROGLOBULIN ANTIGEN MOLECULE COMPLEXES | |
| MXPA04001419A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson. | |
| MXPA04001655A (es) | Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos. | |
| AU6011001A (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
| MXPA02007903A (es) | Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres. | |
| MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
| MXPA04000272A (es) | Derivados de 4-aminociclohexanol sustituidos. | |
| MXPA04004980A (es) | Antagonistas del receptor ccr-3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |